Julian Bonte-Friedheim - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Julian Bonte-Friedheim's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Julian Bonte-Friedheim
Verified
Head Writer, The Perspective
Tel Aviv
Beats
Crypto , Blockchain
gaming, politics
Content
Company Info
The Perspective
The Perspective is a clinical-stage radiopharmaceutical company focused on developing innovative cancer treatments using targeted alpha-particle therapies. Established in February 2023, the company utilizes the alpha-emitting isotope Pb-212 to deliver localized radiation directly to cancer cells, minimizing damage to surrounding healthy tissue. The company specializes in radiopharmaceutical therapies that combine Pb-212 with tumor-specific targeting peptides. They also offer theranostic platforms that use Pb-203 radiotracers for imaging, allowing physicians to confirm tumor characteristics before treatment. This approach helps in selecting suitable patients and reducing toxicity. Perspective Therapeutics collaborates with leading medical institutions and pharmaceutical companies to advance clinical trials and enhance their treatment pipeline, aiming to improve patient outcomes through effective and targeted therapies.
, ,
Founded: 2017